Demir Semra, Cetin Esin Aktas, Unal Derya, Coşkun Raif, Olgac Muge, Gelincik Asli, Colakoglu Bahauddin, Buyukozturk Suna
Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Street, Capa, Istanbul, Turkey.
Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Drug Saf Case Rep. 2018 Jan 2;5(1):2. doi: 10.1007/s40800-017-0067-7.
We present a rare case of generalized fixed drug eruption caused by fluconazole. A 45-year-old female patient was referred to our outpatient clinic because of suspicious drug eruptions that occurred 5 months earlier and resolved within a month. The patient had sequela of hyperpigmentation on her arms, legs, back, and abdomen after oral administration of the fourth dose of 150 mg of fluconazole once daily because of vaginal candidiasis. Patch tests with the culprit drug applied both on unaffected skin areas and over one of the lesions were negative. A lymphocyte transformation test was performed and in response to fluconazole, CD4 T cells significantly proliferated. Because the patient needed a safe antifungal drug for her recurrent vaginal candidiasis symptoms, a single-blind placebo-controlled drug provocation test was performed with itraconazole and was negative. Accordingly, 200 mg of itraconazole once daily was given for 10 days safely.
我们报告一例罕见的由氟康唑引起的全身性固定性药疹。一名45岁女性患者因5个月前出现可疑药疹且在1个月内消退而被转诊至我院门诊。该患者因阴道念珠菌病每日口服150mg氟康唑,在服用第四剂后,手臂、腿部、背部和腹部出现色素沉着后遗症。在未受影响的皮肤区域和其中一个皮损上进行的可疑药物斑贴试验均为阴性。进行了淋巴细胞转化试验,结果显示对氟康唑有反应时,CD4 T细胞显著增殖。由于患者复发性阴道念珠菌病症状需要一种安全的抗真菌药物,因此对伊曲康唑进行了单盲安慰剂对照药物激发试验,结果为阴性。因此,患者安全地每日服用200mg伊曲康唑,持续10天。